- FORPATIENTS sub-brand is a patient-centric suite of healthcare logistics solutions, including for COVID-19 vaccines
- CEVA will introduce a network of more than 40 temperature-controlled airfreight stations around the world by the end of 2021
- The stations will not only service major healthcare gateways in regional markets, but also supply more than 1,450 healthcare trade lanes globally
- CEVA’s healthcare solutions are fully GxP and GDP compliant and meet all regulatory requirements
CEVA Logistics has launched a new sub-brand that offers healthcare and pharmaceutical companies end-to-end, patient-centric logistics solutions, including for COVID-19 vaccines.
The CEVA FORPATIENTS suite of healthcare logistics encompasses temperature-sensitive solutions, pharma and biopharma, medical devices, consumer health, hospital and home care, as well as diagnostic and laboratory services, said the third-party logistics company in an April 7 statement.
Centralizing its global healthcare offerings under the FORPATIENTS umbrella gives greater visibility of CEVA’s range of services to its customers and assures them of the central position of the patient, the third-party logistics company said.
As part of the suite of solutions, the company is also introducing a new temperature-sensitive logistics product that will begin service in the second quarter of 2021.
This entails operating a network of more than 40 temperature-controlled airfreight stations around the world by the end of 2021. Some of the stations will also offer other services, such as contract logistics support.
In all, the stations will allow CEVA not only to service major healthcare gateways in regional markets, but also to supply more than 1,450 healthcare trade lanes globally.
Through the global network, CEVA said it can accommodate a broad range of customer shipments in conjunction with its temperature-sensitive packaging solutions, including active and passive packaging, as well as solutions for out-of-gauge goods.
Moreover, CEVA will provide visibility and monitoring solutions for real-time decisions through embedded location and temperature IoT devices. Information will flow into the company’s supply chain management tool, as well as its global control tower technology for 24/7 shipment monitoring.
This multi-layered approach ensures shipments are maintained at required temperatures, a major concern for healthcare customers, said the company.
CEVA’s healthcare solutions are fully GxP and GDP compliant and meet all national and international regulatory requirements.
“With vaccine and medicine transport growing globally, CEVA will focus its efforts on the 2- to 8-degree Celsius spectrum of products, including certain COVID-19 vaccines, though the company is capable of supporting customers with products, including vaccines, requiring lower temperatures throughout transport,” it said.
In addition, CEVA’s approach includes lane risk assessment, performance and capability management as well as a fully integrated cold chain transportation and storage management solution. The company also provides insight on the sustainability and carbon impact of various routing, packaging and mode of transport choices.
Said Niels Van Namen, executive vice president of CEVA’s global healthcare sector: “Our customers supply the vaccines, medical devices, medication and other support products on which patients around the world depend. For example, diabetic patients should not have to worry about supply chain reliability for their insulin. At CEVA, we’re expanding our temperature-sensitive solutions to ensure that, no matter the logistics challenges faced, patients’ needs are met. Behind every shipment, we see a patient.”
Photo courtesy of CEVA
